SPOTLIGHT: Dynavax touts preclinical bird flu results

Dynavax Technologies announced that preclinical data demonstrates that its flu vaccine shows signs of efficacy against bird flu and may work as a universal flu vaccine. Added with a standard vaccine, researchers said, it allowed for the reduction of the dosage level, a major issue for governments stockpiling vaccines for large populations. Report